RxAll

New Haven, United States Founded: 2015 • Age: 11 yrs
Medicines are authenticated via AI and spectrometers for pharmacy procurement.
Request Access

About RxAll

RxAll is a company based in New Haven (United States) founded in 2015 by Adebayo Alonge and Ankur Kapadia.. RxAll has raised $5.35 million across 5 funding rounds from investors including Katapult, Launch Africa and HAX. RxAll offers products and services including RxScanner, RxDelivered, RxPay, and RxPOS. RxAll operates in a competitive market with competitors including TruTag Technologies, Meditect, Sproxil, PharmaSecure and InfraTrac, among others.

  • Headquarter New Haven, United States
  • Founders Adebayo Alonge, Ankur Kapadia
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Rxall, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.35 M (USD)

    in 5 rounds

  • Latest Funding Round
    $3.15 M (USD), Seed

    Jul 20, 2021

  • Investors
    Katapult

    & 3 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of RxAll

RxAll offers a comprehensive portfolio of products and services, including RxScanner, RxDelivered, RxPay, and RxPOS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI device for authenticating drug quality in real-time.

Secure platform connecting buyers and sellers of verified medicines.

Funding solution to prevent stock-outs for pharmacies and wholesalers.

Software for automating sales, inventory, and payments in pharmacies.

People of RxAll
Headcount 10-50
Employee Profiles 6
Board Members and Advisors 6
Employee Profiles
People
Amy Kao
Co-Founder & Chief Marketing Officer
People
Adebayo Alonge
CEO & Founder
People
Oluwatobiloba Ibuola
Territory Manager
People
Cephas Okongo
Territory Sales Manager - kampala East

Unlock access to complete

Board Members and Advisors
people
Duncan Turner
Advisor
people
Zachariah George
Advisor
people
Mbwana Alliy
Advisor
people
Idris Ayodeji
Advisor

Unlock access to complete

Funding Insights of RxAll

RxAll has successfully raised a total of $5.35M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $3.15 million completed in July 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $3.1M
  • First Round

    (31 Jan 2017)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Seed - RxAll Valuation Launch Africa
Jun, 2021 Amount Seed - RxAll Valuation

investors

Jun, 2019 Amount Seed - RxAll Valuation HAX
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in RxAll

RxAll has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Katapult, Launch Africa and HAX. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Venture capital fund focused on tech companies
Founded Year Domain Location
Startups are accelerated via a 111-day program with seed funding.
Founded Year Domain Location
Investment consulting services are provided to guide client portfolios.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by RxAll

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - RxAll

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Rxall Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of RxAll

RxAll operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TruTag Technologies, Meditect, Sproxil, PharmaSecure and InfraTrac, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Anti-counterfeiting solutions are offered via microscopic edible barcodes for authentication.
domain founded_year HQ Location
Falsified medicines are tracked via AI and blockchain software.
domain founded_year HQ Location
Mobile technology is deployed to authenticate products against counterfeits.
domain founded_year HQ Location
Medication authenticity is verified through SMS by PharmaSecure.
domain founded_year HQ Location
Chemical code tagging solutions are used for counterfeit detection.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about RxAll

When was RxAll founded?

RxAll was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is RxAll located?

RxAll is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.

Who is the current CEO of RxAll?

Adebayo Alonge is the current CEO of RxAll. They have also founded this company.

Is RxAll a funded company?

RxAll is a funded company, having raised a total of $5.35M across 5 funding rounds to date.

What does RxAll do?

RxAll was founded in 2015 in New Haven, United States, within the health technology sector. An AI-based platform is utilized to enable real-time authentication of medicines through spectrometer devices. Deep learning algorithms are applied alongside a cloud dataset of spectral signatures to perform non-destructive verification. Operations include a digital procurement system that allows hospitals and retail pharmacies to source authentic stock from verified pharmaceutical manufacturers and wholesalers.

Who are the top competitors of RxAll?

RxAll's top competitors include TruTag Technologies, Meditect and PharmaSecure.

What products or services does RxAll offer?

RxAll offers RxScanner, RxDelivered, RxPay, and RxPOS.

Who are RxAll's investors?

RxAll has 4 investors. Key investors include Katapult, Launch Africa, HAX, and Keisuke Honda.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available